Efficacy of Immune Checkpoint Inhibitors in KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC).
暂无分享,去创建一个
J. Mazières | C. Mascaux | F. Barlesi | P. Tomasini | M. Boucekine | L. Ouafik | L. Greillier | J. Milia | S. Garcia | L. Mhanna | Arnaud Jeanson | I. Nanni | Julie Biemar | Maxime Souquet-Bressand | Natalyia Khobta | Nicolas Brandone | Mathieu Grangeon | Solène Chaléat